Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Cell and Tissue Technologies Market Worth $30 Billion by 2022 - Increasing Government & Private Funding - Research and Markets

Research and Markets
Posted on: 14 Sep 16

Research and Markets has announced the addition of the "Global Cell and Tissue Technologies Market Insights, Opportunity, Analysis, Market Shares and Forecast 2016 - 2022" report to their offering.

The global cell and tissue technology market is expected to grow at the CAGR of 6.56% during 2016-2022. The market has generated revenue more than $19 billion in 2016 and is projected to reach up to $30 billion by 2022.

Due to increasing chronic cases and inferior's diseases, increasing health industry, increasing advanced technology products and increasing government and private funding for cell based research act as the major factors which increase the market of cell and tissue technology globally. The key drivers which accelerate the market are rising cancer cases. According to World Health Organization, the cancer rate is increasing to reach to 15 million new cases by 2020.

According to WHO report, more than 1.2 million new cases are diagnosed for lung cancer worldwide, one million new cases of breast, 870000 cases of stomach, 560000 cases of cervical, 410000 cases of head and neck cancer and many more. Due to these cases, the demand of cell and tissue technology has increased.

North America has the largest market share of cell and tissue technology followed by Europe and Asia Pacific. The APAC regions have a trend of developing market and various opportunities of growth in China, Japan, Australia, and India and are likely to have huge investments for new investors in the cell and tissue technology market. Drug discovery services outsourcing and government aided funding for novel screening technologies has resulted in growth of Asian markets.

Companies Mentioned:

  • Agilent Technologies, Inc.
  • Becton, Dickinson And Company
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Fluidigm Corporation
  • Ge Healthcare
  • Merck Kgaa
  • Nanostring Technologies, Inc.
  • Olympus Corporation
  • Perkinelmer, Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Sigma Aldrich Corporation
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Geographical Technologies

6. Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/scggb7/global_cell_and

Related Topics: Biotechnology

View source version on businesswire.com: http://www.businesswire.com/news/home/20160914006181/en/

Business Wire
www.businesswire.com

Last updated on: 14/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.